Michael von Poncet MD PhD FESC

Physician Executive | Global Pharma & MedTech Medical Executive | Board member & Advisor | Internist | Cardiologist | Interventional Oncology

Los Angeles, California, United States

About

Physician executive (MD, PhD, FESC) with 20+ years of global leadership experience across pharmaceuticals, biotechnology, and medical devices. Proven track record in Medical Affairs, Clinical Development, Clinical Strategy, and business leadership, serving in senior executive and C-suite roles for leading healthcare organizations including Johnson & Johnson, Novartis, and Sirtex. In-depth knowledge and experience in regional markets, EMEA, G5, United States and Japan as well broad background in global medical affairs leadership. Experienced in building and leading high-performing global teams, driving product strategy from early development through commercialization, supporting regulatory and market access initiatives, and partnering with boards, investors, and executive leadership. Therapeutic expertise includes oncology, cardiovascular disease, immunology, neuroscience, infectious diseases, and rare diseases. Passionate about transforming scientific innovation into meaningful patient outcomes through strategic leadership, operational excellence, and cross-functional collaboration.

Experience

  • Sirtex Medical Limited (Remote)
    • Senior Vice President Medical & Clinical Affairs
      Mar 2024 - Present · 2 yrs 4 mos

    • Vice President Medical Affairs Americas & EMEA
      Jun 2023 - Mar 2024 · 10 mos

  • Fellow at European Society of Cardiology
    Jan 2018 - Present · 8 yrs 6 mos

  • Steering Committee Member at National Hypertension Control Roundtable
    Jan 2023 - Jun 2023 · 6 mos

  • Executive Medical Director US at Novartis
    Oct 2021 - May 2023 · 1 yr 8 mos

  • The Janssen Pharmaceutical Companies of Johnson & Johnson (7 yrs 8 mos)
    • Medical Head of Neuroscience U.S.
      Mar 2021 - Sep 2021 · 7 mos

    • Senior Director, Global Medical Lead Cardiovascular Medicine
      Dec 2017 - Mar 2021 · 3 yrs 4 mos

    • Chief Medical Officer Janssen Germany
      Feb 2014 - Dec 2017 · 3 yrs 11 mos

      Member of the Management Board Janssen Germany General Management and Responsibility for Therapeutic Area Management (Oncology, Immunlogy, Infectious Diseases, Metabolics, CNS Disorders), Medical Goverance and Operations on Medical Education, Scientific Knowledge Management, Regulatory Medicine, Pharmacovigilance, Member of the Management Board